Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1997-04-03
2000-01-25
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514535, 514543, A61K 31235, A61K 3124
Patent
active
060179589
ABSTRACT:
The present invention provides methods for treating cancer, particularly malignant tumors, with thyroxine analogues having no significant hormonal activity. A thyroxine analogue is administered to an afflicted mammal in an amount effective to cause depression or regression of malignant tumor growth or to treat cancer. Particularly preferred thyroxine analogues are those capable of causing about 35 percent or more inhibition of initial velocity of microtubule protein assembly in vitro.
REFERENCES:
patent: 4724234 (1988-02-01), Cone, Jr.
patent: 4816255 (1989-03-01), Ghent et al.
patent: 5736576 (1998-04-01), Kun et al.
Chen, et al., "A Novel Thyroid Hormone Analog Binds to Tubulin and Induces Apoptosis and Mitotic Arrest in Human Cancer Cells," FASEB--Abstract (1997).
Bauer et al., "Modification of Growth Related Enzymatic Pathways and Apparent Loss of Tumorigenicity of a Ras-Transformed Bovine Endothelial Cell Line by Treatment with 5-Iodo-6-Amino-1, 2-Benzopyrone (INH.sub.2 BP)," International J. of Oncology 8:239-252 (1996).
Borrows et al., "The Synthesis of Thyroxine and Related Substances. Part I. The Preparation of Tyrosine and Some of its Derivatives, and a New Route to Thyroxine," J. Chem. Soc. 1949 (Supp. Issue No. 1):S185-S190 (1949).
Borrows et al., "The Synthesis of Thyroxine and Related Substances. Part II. Preparation of Dinitrophenyl Ethers," J. Chem. Soc. 1949 (Supp. Issue No. 1):S190-S199 (1949).
Borrows et al., "Synthesis of Thyroxine and Realted Substances. I. The Preparation of Tyrosine and Some of its Derivatives and a New Route to Thyroxine," Chem. Abstr. 44:574h (1950).
Borrows et al., Diphenyl Ethers, Chem. Abstr. 45:P7594b (1951).
Burton, et al., "Traction forces of cytokinesis measured with optically modified elastic substrate," Nature 385:450-454 (1997).
Clayton et al., "The Synthesis of Thyroxine and Related Substances. Part VIII. The Preparation of Some Halogeno- and Nitro-diphenyl Ethers," J. Am. Chem. Soc. 1951:2467-2473 (1951).
Clayton et al., "Synthesis of Thyroxine and Realted Substances. VIII. The Preparation of Some Halo- and Nitrodiphenyl Ethers," Chem. Abstr. 46:8056g (1952).
Cole, et al., "Inhibition of HIV-1 IIIb Replication in AA-2 Cells in Culture by Two Ligands of Poly (ADP-Ribose) Polymerase: 6-Amino-1, 2-benzopyrone and 5-iodo-6-amino-1, 2-benzopyrone," Biochem Biophys. Res. Commun. 180:504-514 (1991).
Crowder et al., "Bisbenzylisoquinolines," Chem. Abstr. 52:17163d (1958).
Crowder et al., "Bisbenzylisoquinolines. Part II. The Synthesis of 5-(2-Aminoethyl)-4'-carboxy-2,3-dimethoxydiphenyl Ether," J. Chem. Soc. 1958:2142-2149 (1958).
Dunphy, "The Decision to Enter Mitosis," Trends Cell. Biol. 4:202-207 (1994).
Dykes et al., "Response of Human Tumor Xenografts in Athymic Nude Mice to Docetaxel," BIOSIS 95:487870 (1995).
Gemmill et al., "3-Iodo-, 3, 3'-Diiodo- and 3, 3'-Diiodo-5-Bromthyroxine," J. Am. Chem. Soc. 78:2434-2436, (1956).
Grinberg et al., "Studies with Mouse Pituitary Thyrotropic Tumors. V. Effect of Various Thyroxine Analogs on Growth and Secretion," Chem. Abstr. 57:14335d (1962).
Grinberg et al., "Studies with Mouse Pituitary Thyrotropic Tumors. V. Effect of Various Thyroxine Analogs on Growth and Secretion," Cancer Research 22:835-841 (1962).
Grutzmeier, S., "Myxoedema in a Case of Acute Myeloid Leukemia," EMBASE 85:118288 (1985).
Jorgensen, "Thyroid Hormones and Analogues, I. Synthesis, Physical Properties and Theoretical Calculations," In: Hormonal Proteins and Peptides VI:57-105, C.H. Li, Ed., Academic Press, NY (1978).
Jorgensen, "Thryoid Hormones and Analogues. II. Structure-Activity Relationships," In: Hormonal Proteins and Peptides, VI:107-204, C.H. Li, Ed., Academic Press, NY (1978).
Kawabe et al., "HOXII Interacts with Protein Phosphatase PP2a and PP1 and Disrupts G2/M Cell Cycle Checkpoint," Nature 385:454-458 (1997).
Kumaoka et al., "The Effect of Thyroxine analogs on a Transplantable-Mouse Pituitary Tumor," Chem. Abstr. 54:18779i (1960).
Kumaoka et al., "The Effect of Thyroxine Analogues on a Transplantable Mouse Pituitary Tumor," Endocrinology 66:32-38 (1960).
Kun et al., "Induction of Tumor Apotosis by methyl-3, 5-diiodo-4-(4'-methoxyphenoxy) benzoate (DIME)", Abstract No. 102, Int. J. Oncol. 9:supplement 829 (1996).
Masuda et al., "Triiodothyroformic Acid. Synthesis of Triidothyroformic Acid and its Derivatives," Takeda Kenkyusho Ho 29(4):545-552 (in Japanese) (1970).
Masuda et al., "Thyroxine Related Compounds. I. Synthesis of Triiodothyroformic Acid and its Derivatives," Chem. Abstr. 75:40431q (1971).
Meltzer et al., "Thyroxine Analogs," J. Org. Chem. 22:1577-1581 (1957).
Meltzer et al., "Thyroxine Analogs," Chem. Abstr. 52:7210d (1958).
Mendeleyev et al., "Structural Specificity and Tumoricidal Action of Methyl-3, 5-Diiodo-4-(4'-Methoxyphenoxy) Benzoate (DIME)," Intl. J. Oncol. 10:689-695 (1997).
Mitchison et al., "Microtubule Assembly Nucleated by Isolated Centrosomes," Nature 312:232-237 (1984).
Money et al., "The Effect of Changes in Chemical Structure of Some Thyroxine Analogs on the Metamorphosis of Rana Piplens Tadpoles," Chem. Abstr. 52:20701a (1958).
Money et al., "The Effect of Change in Chemical Structure of Some Thyroxine Analogues on the Metamorphosis of Rana Pipiens Tadpoles," Endocrinology 63:20-28 (1958).
Money et al., "Effect of Various Thyroxine Analogs on Suppression of Iodine-131 Uptake by the Rat Thyroid," Chem. Abstr. 53:14327i (1959).
Money et al., "The Effect of Various Thyroxine Analogues on Suppression of Iodine-131 Uptake by the Rat Thyroid.sup.1," Endocrinology 64:123-125 (1959).
Osbourne et al., "Effect of Estrogens and Antiestrogens on Growth of Human Breast Cancer Cells in Athymic Nude Mice," Cancer Res. 45:584-590 (1985).
Ozzello & Sordat, "Behaviour of Tumors Produced by Transplantation of Human Mammary Cell Lines in Athymic Nude Mice," Eur. J. Cancer 16:553-559 (1980).
Pinkel et al., "Cytogentic Analysis Using Quantitative High-Sensitivity Fluorescence Hybridization," Proc. Natl. Acad. Sci. U.S.A. 83:2934-2938 (1986).
Siebert et al., "Clonal Variation of MCF-7 Breast Cancer Cells in Vitro and in Athymic Nude Mice," Cancer Res. 43:2223-2239 (1983).
Smythe et al., "Coupling of Mitosis to the Completion of S Phase in Xenopus Occurs via Modulation of the Tyrosine Kinase that Phosphorylates P34.sup.cdc2," Cell 68:787-797 (1992).
Stasilli et al., "Analogs in Rats," Chem. Abstr. 53:14327ci (1959).
Stasilli et al., "Antigoitrogenic and Calorigenic Activities of Thyroxine Analogues in Rats," Endocrinology 64:62-82 (1959).
Tiwari, et al., "A pH and temperature-dependent cycling method that doubles the yield of microtubule protein," Anal. Biochem. 215:96-103 (1993).
Tomita et al., "Synthesis and Biological Activity of Some Triilodinated Analogues of Thyroxine," J. Biol. Chem. 219:595-604 (1956).
Usui et al., "Phosphoportein Phosphatases in Human Erythrocyte Cytosol," J. Biol. Chem. 258:10455-10463 (1983).
Vidair et al., "Evaluation of a Role for Intracellular Na.sup.+, K.sup.+, .sup.Ca2+, and Mg.sup.2+ in Hyperthermic Cell Killing," Radiation Res. 105:187-200 (1986).
Warri et al., "Estrogen Suppression of erbB2 Expression is Associated with Increased Growth Rate of Zr-75-1 Human Breast Cancer Cells In Vitro and in Nude Mice," Intl. J. Cancer 49:616-623 (1991).
Wera et al., "Deregulation of Transitional Control of the 65 kDa Regulatory Subunit (PR65 Alpha) of Protein Phosphatase 2A leads to Multinucleated Cells," J. Biol. Chem. 270:21374-21381 (1995).
Wera et al., "Serine/Threonine Protein Phosphatasesm,". J. 311:17-29 (1995).
Wertz, et al., "Diverse Molecular Provocation of Programmed Cell Death," TIBS 21:359-364 (1996).
Zhen et al., "Cellular Analysis of the Mode of Action of Methyl-3-5-diiodo-4-(4'-Methoxyphenoxy) Benzoate (DIME) on Tumor Cells," Intl. J. Oncol. 10:905-910 (1997).
Kun Ernest
Mendeleyev Jerome
Goldberg Jerome D.
Halluin Albert P.
Octamer, Inc.
LandOfFree
Method of treating malignant tumors with thyroxine analogues hav does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating malignant tumors with thyroxine analogues hav, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating malignant tumors with thyroxine analogues hav will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2316321